Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2026 08:45 ET | Source: Propanc Biopharma, Inc.

Propanc Biopharma’s Lead Asset PRP Shows >85% Tumor Growth Inhibition in Preclinical Pancreatic Models

Preclinical data shines: >85% tumor growth inhibition in pancreatic models, reduced fibrosis and resistance markers, and a gentler safety profile
February 27, 2026 04:02 ET | Source: Research and Markets

Global Ferroptosis Targeting Therapy Market Opportunity Report 2026: Therapeutic Approaches, Technology Development Platforms & Clinical Trials Insights By Company, Country, Indication & Phase

Dublin, Feb. 27, 2026 (GLOBE NEWSWIRE) -- The "Global Ferroptosis Targeting Therapy Market Opportunity, Therapeutic Approaches, Technology Development Platforms & Clinical Trials Insight 2026"...
February 25, 2026 06:57 ET | Source: Research and Markets

Patient Derived Xenografts/PDX Models Market Research and Global Forecast Report 2025-2030

Dublin, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The "Patient Derived Xenografts/PDX Models Market by Type (Mouse, Rat), Service (Model Creation, Characterization), Implantation Method (Subcutaneous),...
February 12, 2026 11:07 ET | Source: Research and Markets

Global Pharmaceutical R&D Directory 2026: Licensing Trends, Biotechnology Advancements, Preclinical and Clinical Development, Avenues for Growth and Innovation

Dublin, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The "The Global Pharmaceutical R&D Directory" directory has been added to ResearchAndMarkets.com's offering. The Global Pharmaceutical R&D...
February 11, 2026 10:00 ET | Source: Dewpoint Therapeutics

Dewpoint Therapeutics Selects First-in-Class MYC Condensate Modulator Development Candidate

Dewpoint Therapeutics selects a first-in-class small molecule development candidate for multiple cancers in which MYC dependence is a central driver.
February 05, 2026 07:18 ET | Source: Research and Markets

Crohn's Disease (Regional Enteritis) Global Clinical Trials Market Review 2025: G7 and E7 Activities, Trial Status, Sponsor Insights, Enrollment Trends, Company Listings, Unaccomplished Trials

Dublin, Feb. 05, 2026 (GLOBE NEWSWIRE) -- The "Crohn's Disease (Regional Enteritis) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This...
January 23, 2026 09:58 ET | Source: Research and Markets

MYC Targeting Therapies Market Research Report 2026-2030: 10 Therapies in Clinical Trials, 5 Targeting Platforms, Clinical Studies Start & Expected Completion Timeline by Indication

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "MYC Targeting Therapies Market Opportunity, Targeting Approaches, Technology Development Platforms & Clinical Trials Insight 2026" report has been...
January 23, 2026 06:23 ET | Source: Research and Markets

In Silico Clinical Trials Market Research Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "In Silico Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
January 22, 2026 09:16 ET | Source: Research and Markets

Mice Model Market Forecast 2026-2032: Analyzing Ethical Advances, Integrated Informatics, and the Shift Towards Personalized Medicine

Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Mice Model Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Mice Model Market demonstrates significant...
January 06, 2026 09:16 ET | Source: Research and Markets

SYK Inhibitors Market, Drug Price, Sales & Clinical Trials Outlook, 2030 - Ongoing Global Trials and Promising Candidates Like Sovleplenib Create Strong Investment and Innovation Opportunities

Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The "SYK Inhibitors Market, Drug Price, Sales & Clinical Trials Outlook 2030" report has been added to ResearchAndMarkets.com's offering.Report...